Mr. McGuinty, as I mentioned in my presentation, I have proposed a couple of amendments to the bill.
Our perspective is that we have a CEPA review process for the review of chemicals, for their risk assessment, and for their risk management. If you, as a committee, have concerns about these substances, refer them back to Health Canada, to Environment Canada, for further assessment. As mentioned, they have already been assessed a number of times.
With regard to Health Canada, Health Canada is, as I'm sure you're aware, the arm of the government that approves the medical devices for use. There is a very stringent screening process for approval of these medical devices, and they have been doing that for decades.
I would just further point out that there is not one documented case of a Canadian being harmed by any of these medical devices. I'll leave it at that.